Ellington Management Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-23,300
| Closed | -$303K | – | 764 |
|
|
2019
Q3 | $303K | Buy |
+23,300
| New | +$303K | 0.05% | 347 |
|
|
2019
Q2 | – | Sell |
-11,100
| Closed | -$175K | – | 799 |
|
|
2019
Q1 | $175K | Buy |
+11,100
| New | +$175K | 0.03% | 467 |
|
|
2017
Q2 | – | Sell |
-16,400
| Closed | -$341K | – | 932 |
|
|
2017
Q1 | $341K | Buy |
+16,400
| New | +$341K | 0.01% | 418 |
|
|
2015
Q3 | – | Sell |
-19,100
| Closed | -$611K | – | 932 |
|
|
2015
Q2 | $611K | Buy |
+19,100
| New | +$611K | 0.15% | 188 |
|